Items Tagged ‘antibody therapy’

September 2nd, 2015

Immunotherapy Benefits Patients with Drug-Resistant Multiple Myeloma

By

In its first clinical trial, a breakthrough antibody therapy produced at least partial remissions in a third of patients with multiple myeloma who had exhausted multiple prior treatments, investigators at Dana-Farber Cancer Institute and other organizations report today online in the New England Journal of Medicine. The drug, daratumumab, proved generally safe in patients even […]

View full entry

Tags: antibody therapy, clinical trial, daratumumab, monoclonal antibody, Multiple Myeloma, News, Recurrent Multiple Myeloma


May 20th, 2015

Xilonix™ Promising as Treatment for Non–Small Cell Lung Cancer

By

The new targeted agent Xilonix™ appears effective in the treatment a non–small cell lung cancer (NSCLC). The biotechnology company XBoitech Inc recently announced clinical trial findings for the drug.[i],[ii] Xilonix is a type of drug known as a true human antibody. These types of drugs use antibodies that are made in the lab rather than […]

View full entry

Tags: antibody therapy, Lung Cancer - Non-Small Cell, News, non-small cell lung cancer, nsclc, true human antibody, xilonix